nodes	percent_of_prediction	percent_of_DWPC	metapath
Melatonin—MT3—breast cancer	0.147	0.37	CbGaD
Melatonin—NQO2—breast cancer	0.125	0.315	CbGaD
Melatonin—CYP1B1—breast cancer	0.0422	0.107	CbGaD
Melatonin—CYP19A1—Exemestane—breast cancer	0.0373	0.1	CbGbCtD
Melatonin—ESR1—Fluoxymesterone—breast cancer	0.0319	0.0857	CbGbCtD
Melatonin—ESR1—Toremifene—breast cancer	0.0319	0.0857	CbGbCtD
Melatonin—CYP19A1—Letrozole—breast cancer	0.0317	0.0852	CbGbCtD
Melatonin—CYP19A1—breast cancer	0.031	0.0783	CbGaD
Melatonin—ESR1—Fulvestrant—breast cancer	0.0296	0.0797	CbGbCtD
Melatonin—ESR1—breast cancer	0.0285	0.072	CbGaD
Melatonin—CYP19A1—Anastrozole—breast cancer	0.0283	0.076	CbGbCtD
Melatonin—CYP1A1—breast cancer	0.0228	0.0576	CbGaD
Melatonin—ESR1—Raloxifene—breast cancer	0.0176	0.0474	CbGbCtD
Melatonin—CYP19A1—Raloxifene—breast cancer	0.0143	0.0384	CbGbCtD
Melatonin—CYP1A1—Toremifene—breast cancer	0.014	0.0376	CbGbCtD
Melatonin—MPO—Carboplatin—breast cancer	0.0128	0.0345	CbGbCtD
Melatonin—ESR1—Tamoxifen—breast cancer	0.0116	0.0313	CbGbCtD
Melatonin—CYP1B1—Tamoxifen—breast cancer	0.0116	0.0313	CbGbCtD
Melatonin—CYP1B1—Mitoxantrone—breast cancer	0.0114	0.0305	CbGbCtD
Melatonin—CYP19A1—Tamoxifen—breast cancer	0.00944	0.0254	CbGbCtD
Melatonin—CYP1B1—Paclitaxel—breast cancer	0.00907	0.0244	CbGbCtD
Melatonin—CYP19A1—Paclitaxel—breast cancer	0.00735	0.0198	CbGbCtD
Melatonin—CYP1A2—Anastrozole—breast cancer	0.00684	0.0184	CbGbCtD
Melatonin—CYP1B1—Docetaxel—breast cancer	0.00656	0.0176	CbGbCtD
Melatonin—CYP1A2—Toremifene—breast cancer	0.00625	0.0168	CbGbCtD
Melatonin—CYP2C9—Anastrozole—breast cancer	0.00616	0.0165	CbGbCtD
Melatonin—CYP1A1—Tamoxifen—breast cancer	0.00511	0.0137	CbGbCtD
Melatonin—CYP2C19—Lapatinib—breast cancer	0.00494	0.0133	CbGbCtD
Melatonin—CYP1B1—Doxorubicin—breast cancer	0.00489	0.0131	CbGbCtD
Melatonin—CYP2C9—Idarubicin—breast cancer	0.00467	0.0125	CbGbCtD
Melatonin—CYP19A1—corpus luteum—breast cancer	0.00295	0.071	CbGeAlD
Melatonin—SLC22A8—Methotrexate—breast cancer	0.00261	0.00703	CbGbCtD
Melatonin—CYP2C9—Capecitabine—breast cancer	0.00256	0.00687	CbGbCtD
Melatonin—CYP2C19—Tamoxifen—breast cancer	0.00247	0.00665	CbGbCtD
Melatonin—CYP1A2—Tamoxifen—breast cancer	0.00228	0.00614	CbGbCtD
Melatonin—CYP2C9—Tamoxifen—breast cancer	0.00206	0.00553	CbGbCtD
Melatonin—CYP1A2—Fluorouracil—breast cancer	0.00168	0.00452	CbGbCtD
Melatonin—CYP2C9—Paclitaxel—breast cancer	0.0016	0.0043	CbGbCtD
Melatonin—CYP2C9—Fluorouracil—breast cancer	0.00152	0.00407	CbGbCtD
Melatonin—CALR—mammary gland—breast cancer	0.00129	0.031	CbGeAlD
Melatonin—EPX—female reproductive system—breast cancer	0.0012	0.0289	CbGeAlD
Melatonin—EPX—bone marrow—breast cancer	0.00113	0.0273	CbGeAlD
Melatonin—CALR—nipple—breast cancer	0.00107	0.0256	CbGeAlD
Melatonin—ASMT—female reproductive system—breast cancer	0.000995	0.0239	CbGeAlD
Melatonin—IDO1—female reproductive system—breast cancer	0.00091	0.0219	CbGeAlD
Melatonin—CALR—embryo—breast cancer	0.00088	0.0212	CbGeAlD
Melatonin—ASMT—endocrine gland—breast cancer	0.000842	0.0202	CbGeAlD
Melatonin—IDO1—endocrine gland—breast cancer	0.00077	0.0185	CbGeAlD
Melatonin—CALR—epithelium—breast cancer	0.000718	0.0173	CbGeAlD
Melatonin—CALR—skin of body—breast cancer	0.000683	0.0164	CbGeAlD
Melatonin—CALR—endometrium—breast cancer	0.000644	0.0155	CbGeAlD
Melatonin—NQO2—nipple—breast cancer	0.000602	0.0145	CbGeAlD
Melatonin—CALR—uterus—breast cancer	0.000594	0.0143	CbGeAlD
Melatonin—CALR—pituitary gland—breast cancer	0.000583	0.014	CbGeAlD
Melatonin—CALR—adipose tissue—breast cancer	0.000581	0.014	CbGeAlD
Melatonin—MT3—endocrine gland—breast cancer	0.000573	0.0138	CbGeAlD
Melatonin—CALR—female reproductive system—breast cancer	0.000534	0.0128	CbGeAlD
Melatonin—IDO1—lymph node—breast cancer	0.000533	0.0128	CbGeAlD
Melatonin—CALR—adrenal gland—breast cancer	0.000521	0.0125	CbGeAlD
Melatonin—CALR—bone marrow—breast cancer	0.000504	0.0121	CbGeAlD
Melatonin—CALM3—mammary gland—breast cancer	0.000503	0.0121	CbGeAlD
Melatonin—CALR—female gonad—breast cancer	0.000486	0.0117	CbGeAlD
Melatonin—CALR—endocrine gland—breast cancer	0.000452	0.0109	CbGeAlD
Melatonin—Sumatriptan—SLCO1B1—breast cancer	0.000428	0.278	CrCbGaD
Melatonin—CYP1B1—mammary gland—breast cancer	0.000428	0.0103	CbGeAlD
Melatonin—CALM3—nipple—breast cancer	0.000416	0.01	CbGeAlD
Melatonin—ESR1—mammary gland—breast cancer	0.000398	0.00956	CbGeAlD
Melatonin—MT3—lymph node—breast cancer	0.000396	0.00951	CbGeAlD
Melatonin—CALM1—mammary gland—breast cancer	0.000393	0.00946	CbGeAlD
Melatonin—NQO2—endometrium—breast cancer	0.000363	0.00873	CbGeAlD
Melatonin—NQO2—uterus—breast cancer	0.000335	0.00805	CbGeAlD
Melatonin—NQO2—pituitary gland—breast cancer	0.000329	0.0079	CbGeAlD
Melatonin—NQO2—adipose tissue—breast cancer	0.000328	0.00787	CbGeAlD
Melatonin—CALM2—nipple—breast cancer	0.000327	0.00786	CbGeAlD
Melatonin—CALM1—nipple—breast cancer	0.000325	0.00782	CbGeAlD
Melatonin—CALR—lymph node—breast cancer	0.000312	0.0075	CbGeAlD
Melatonin—MPO—epithelium—breast cancer	0.000312	0.0075	CbGeAlD
Melatonin—NQO2—female reproductive system—breast cancer	0.000301	0.00724	CbGeAlD
Melatonin—MPO—skin of body—breast cancer	0.000297	0.00713	CbGeAlD
Melatonin—NQO2—adrenal gland—breast cancer	0.000294	0.00706	CbGeAlD
Melatonin—CYP2C9—mammary gland—breast cancer	0.000291	0.00699	CbGeAlD
Melatonin—NQO2—bone marrow—breast cancer	0.000284	0.00683	CbGeAlD
Melatonin—Nabumetone—PTGS1—breast cancer	0.000281	0.183	CrCbGaD
Melatonin—NQO2—female gonad—breast cancer	0.000274	0.00658	CbGeAlD
Melatonin—ESR1—embryo—breast cancer	0.000271	0.00652	CbGeAlD
Melatonin—CALM2—embryo—breast cancer	0.00027	0.00648	CbGeAlD
Melatonin—CALM1—embryo—breast cancer	0.000269	0.00645	CbGeAlD
Melatonin—NQO2—endocrine gland—breast cancer	0.000255	0.00612	CbGeAlD
Melatonin—CYP1A2—nipple—breast cancer	0.000254	0.00609	CbGeAlD
Melatonin—MPO—pituitary gland—breast cancer	0.000253	0.00608	CbGeAlD
Melatonin—CALM3—endometrium—breast cancer	0.000251	0.00604	CbGeAlD
Melatonin—CYP1A1—nipple—breast cancer	0.00025	0.00601	CbGeAlD
Melatonin—CALM3—uterus—breast cancer	0.000232	0.00557	CbGeAlD
Melatonin—CYP19A1—endometrium—breast cancer	0.000229	0.00549	CbGeAlD
Melatonin—CALM3—pituitary gland—breast cancer	0.000227	0.00547	CbGeAlD
Melatonin—CYP1B1—skin of body—breast cancer	0.000227	0.00545	CbGeAlD
Melatonin—CALM3—adipose tissue—breast cancer	0.000227	0.00545	CbGeAlD
Melatonin—MPO—adrenal gland—breast cancer	0.000226	0.00543	CbGeAlD
Melatonin—ESR1—epithelium—breast cancer	0.000221	0.00532	CbGeAlD
Melatonin—CALM2—epithelium—breast cancer	0.00022	0.00529	CbGeAlD
Melatonin—CALM1—epithelium—breast cancer	0.000219	0.00527	CbGeAlD
Melatonin—MPO—bone marrow—breast cancer	0.000219	0.00526	CbGeAlD
Melatonin—CYP19A1—uterus—breast cancer	0.000211	0.00506	CbGeAlD
Melatonin—CALM2—skin of body—breast cancer	0.000209	0.00503	CbGeAlD
Melatonin—CALM1—skin of body—breast cancer	0.000208	0.00501	CbGeAlD
Melatonin—CYP19A1—adipose tissue—breast cancer	0.000206	0.00495	CbGeAlD
Melatonin—CALM3—adrenal gland—breast cancer	0.000203	0.00488	CbGeAlD
Melatonin—ESR1—endometrium—breast cancer	0.000199	0.00477	CbGeAlD
Melatonin—CALM2—endometrium—breast cancer	0.000197	0.00474	CbGeAlD
Melatonin—CYP1B1—uterus—breast cancer	0.000197	0.00473	CbGeAlD
Melatonin—CALM3—bone marrow—breast cancer	0.000197	0.00473	CbGeAlD
Melatonin—Midodrine—CYP2D6—breast cancer	0.000197	0.128	CrCbGaD
Melatonin—CALM1—endometrium—breast cancer	0.000197	0.00472	CbGeAlD
Melatonin—MPO—endocrine gland—breast cancer	0.000196	0.00471	CbGeAlD
Melatonin—CYP1B1—pituitary gland—breast cancer	0.000193	0.00465	CbGeAlD
Melatonin—CYP1B1—adipose tissue—breast cancer	0.000193	0.00463	CbGeAlD
Melatonin—CALM3—female gonad—breast cancer	0.000189	0.00455	CbGeAlD
Melatonin—CYP19A1—female reproductive system—breast cancer	0.000189	0.00455	CbGeAlD
Melatonin—Sumatriptan—ABCG2—breast cancer	0.000186	0.121	CrCbGaD
Melatonin—CYP19A1—adrenal gland—breast cancer	0.000185	0.00444	CbGeAlD
Melatonin—ESR1—uterus—breast cancer	0.000183	0.0044	CbGeAlD
Melatonin—CALM2—uterus—breast cancer	0.000182	0.00437	CbGeAlD
Melatonin—CALM1—uterus—breast cancer	0.000181	0.00435	CbGeAlD
Melatonin—ESR1—pituitary gland—breast cancer	0.00018	0.00432	CbGeAlD
Melatonin—ESR1—adipose tissue—breast cancer	0.000179	0.0043	CbGeAlD
Melatonin—CALM2—pituitary gland—breast cancer	0.000179	0.00429	CbGeAlD
Melatonin—CALM2—adipose tissue—breast cancer	0.000178	0.00428	CbGeAlD
Melatonin—CALM1—pituitary gland—breast cancer	0.000178	0.00427	CbGeAlD
Melatonin—CALM1—adipose tissue—breast cancer	0.000177	0.00426	CbGeAlD
Melatonin—CYP1B1—female reproductive system—breast cancer	0.000177	0.00425	CbGeAlD
Melatonin—NQO2—lymph node—breast cancer	0.000176	0.00423	CbGeAlD
Melatonin—CYP1B1—adrenal gland—breast cancer	0.000173	0.00415	CbGeAlD
Melatonin—CYP19A1—female gonad—breast cancer	0.000172	0.00414	CbGeAlD
Melatonin—CYP1A1—epithelium—breast cancer	0.000168	0.00405	CbGeAlD
Melatonin—ESR1—female reproductive system—breast cancer	0.000165	0.00395	CbGeAlD
Melatonin—CALM2—female reproductive system—breast cancer	0.000164	0.00393	CbGeAlD
Melatonin—CALM1—female reproductive system—breast cancer	0.000163	0.00391	CbGeAlD
Melatonin—CYP1B1—female gonad—breast cancer	0.000161	0.00387	CbGeAlD
Melatonin—Nabumetone—PTGS2—breast cancer	0.000161	0.104	CrCbGaD
Melatonin—ESR1—adrenal gland—breast cancer	0.000161	0.00386	CbGeAlD
Melatonin—CYP19A1—endocrine gland—breast cancer	0.00016	0.00385	CbGeAlD
Melatonin—CYP1A1—skin of body—breast cancer	0.00016	0.00385	CbGeAlD
Melatonin—CALM2—adrenal gland—breast cancer	0.00016	0.00384	CbGeAlD
Melatonin—CALM1—adrenal gland—breast cancer	0.000159	0.00382	CbGeAlD
Melatonin—CALM2—bone marrow—breast cancer	0.000154	0.00371	CbGeAlD
Melatonin—CALM1—bone marrow—breast cancer	0.000154	0.00369	CbGeAlD
Melatonin—CYP1B1—endocrine gland—breast cancer	0.00015	0.0036	CbGeAlD
Melatonin—ESR1—female gonad—breast cancer	0.00015	0.0036	CbGeAlD
Melatonin—CALM2—female gonad—breast cancer	0.000149	0.00358	CbGeAlD
Melatonin—CALM1—female gonad—breast cancer	0.000148	0.00356	CbGeAlD
Melatonin—ESR1—endocrine gland—breast cancer	0.000139	0.00335	CbGeAlD
Melatonin—CYP1A1—uterus—breast cancer	0.000139	0.00334	CbGeAlD
Melatonin—CALM2—endocrine gland—breast cancer	0.000138	0.00333	CbGeAlD
Melatonin—CALM1—endocrine gland—breast cancer	0.000138	0.00331	CbGeAlD
Melatonin—CYP1A1—adipose tissue—breast cancer	0.000136	0.00327	CbGeAlD
Melatonin—MPO—lymph node—breast cancer	0.000136	0.00326	CbGeAlD
Melatonin—CYP2C19—endocrine gland—breast cancer	0.000131	0.00316	CbGeAlD
Melatonin—CYP1A1—female reproductive system—breast cancer	0.000125	0.00301	CbGeAlD
Melatonin—CALM3—lymph node—breast cancer	0.000122	0.00293	CbGeAlD
Melatonin—CYP2C9—female reproductive system—breast cancer	0.00012	0.00289	CbGeAlD
Melatonin—CYP1A1—female gonad—breast cancer	0.000114	0.00274	CbGeAlD
Melatonin—Almotriptan—CYP2D6—breast cancer	0.000113	0.0733	CrCbGaD
Melatonin—CYP19A1—lymph node—breast cancer	0.000111	0.00266	CbGeAlD
Melatonin—CYP1A2—endocrine gland—breast cancer	0.000107	0.00258	CbGeAlD
Melatonin—CYP1A1—endocrine gland—breast cancer	0.000106	0.00254	CbGeAlD
Melatonin—CYP1B1—lymph node—breast cancer	0.000104	0.00249	CbGeAlD
Melatonin—CYP2C9—endocrine gland—breast cancer	0.000102	0.00245	CbGeAlD
Melatonin—Almotriptan—CYP3A4—breast cancer	9.69e-05	0.0628	CrCbGaD
Melatonin—ESR1—lymph node—breast cancer	9.62e-05	0.00231	CbGeAlD
Melatonin—CALM2—lymph node—breast cancer	9.57e-05	0.0023	CbGeAlD
Melatonin—CALM1—lymph node—breast cancer	9.52e-05	0.00229	CbGeAlD
Melatonin—Sumatriptan—ABCB1—breast cancer	7.76e-05	0.0504	CrCbGaD
Melatonin—CYP1A1—lymph node—breast cancer	7.32e-05	0.00176	CbGeAlD
Melatonin—Asthenia—Mitoxantrone—breast cancer	3.09e-05	0.00033	CcSEcCtD
Melatonin—Asthenia—Irinotecan—breast cancer	3.09e-05	0.00033	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	3.08e-05	0.00033	CcSEcCtD
Melatonin—Stomatitis—Epirubicin—breast cancer	3.07e-05	0.000328	CcSEcCtD
Melatonin—Hypertension—Capecitabine—breast cancer	3.05e-05	0.000326	CcSEcCtD
Melatonin—Hypersensitivity—Fluorouracil—breast cancer	3.04e-05	0.000325	CcSEcCtD
Melatonin—Dry mouth—Docetaxel—breast cancer	3.04e-05	0.000325	CcSEcCtD
Melatonin—Gastrointestinal disorder—Paclitaxel—breast cancer	3.03e-05	0.000324	CcSEcCtD
Melatonin—Fatigue—Paclitaxel—breast cancer	3.03e-05	0.000324	CcSEcCtD
Melatonin—Asthenia—Gemcitabine—breast cancer	3.01e-05	0.000322	CcSEcCtD
Melatonin—Chest pain—Capecitabine—breast cancer	3e-05	0.000321	CcSEcCtD
Melatonin—Arthralgia—Capecitabine—breast cancer	3e-05	0.000321	CcSEcCtD
Melatonin—Pain—Paclitaxel—breast cancer	3e-05	0.000321	CcSEcCtD
Melatonin—Haematuria—Epirubicin—breast cancer	3e-05	0.000321	CcSEcCtD
Melatonin—Anxiety—Capecitabine—breast cancer	2.99e-05	0.00032	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	2.98e-05	0.000319	CcSEcCtD
Melatonin—Urinary tract disorder—Methotrexate—breast cancer	2.98e-05	0.000319	CcSEcCtD
Melatonin—Hepatobiliary disease—Epirubicin—breast cancer	2.98e-05	0.000318	CcSEcCtD
Melatonin—Weight increased—Doxorubicin—breast cancer	2.97e-05	0.000318	CcSEcCtD
Melatonin—Pruritus—Gemcitabine—breast cancer	2.97e-05	0.000317	CcSEcCtD
Melatonin—Nausea—Thiotepa—breast cancer	2.96e-05	0.000317	CcSEcCtD
Melatonin—Urethral disorder—Methotrexate—breast cancer	2.96e-05	0.000316	CcSEcCtD
Melatonin—Infection—Docetaxel—breast cancer	2.96e-05	0.000316	CcSEcCtD
Melatonin—Dry mouth—Capecitabine—breast cancer	2.94e-05	0.000314	CcSEcCtD
Melatonin—Shock—Docetaxel—breast cancer	2.93e-05	0.000313	CcSEcCtD
Melatonin—Nervous system disorder—Docetaxel—breast cancer	2.92e-05	0.000312	CcSEcCtD
Melatonin—Pruritus—Fluorouracil—breast cancer	2.92e-05	0.000312	CcSEcCtD
Melatonin—Thrombocytopenia—Docetaxel—breast cancer	2.91e-05	0.000312	CcSEcCtD
Melatonin—Infestation NOS—Doxorubicin—breast cancer	2.91e-05	0.000311	CcSEcCtD
Melatonin—Infestation—Doxorubicin—breast cancer	2.91e-05	0.000311	CcSEcCtD
Melatonin—Skin disorder—Docetaxel—breast cancer	2.89e-05	0.000309	CcSEcCtD
Melatonin—Gastrointestinal pain—Paclitaxel—breast cancer	2.87e-05	0.000307	CcSEcCtD
Melatonin—Infection—Capecitabine—breast cancer	2.86e-05	0.000306	CcSEcCtD
Melatonin—Dizziness—Irinotecan—breast cancer	2.85e-05	0.000304	CcSEcCtD
Melatonin—Stomatitis—Doxorubicin—breast cancer	2.84e-05	0.000304	CcSEcCtD
Melatonin—Shock—Capecitabine—breast cancer	2.83e-05	0.000303	CcSEcCtD
Melatonin—Nervous system disorder—Capecitabine—breast cancer	2.82e-05	0.000302	CcSEcCtD
Melatonin—Eye disorder—Methotrexate—breast cancer	2.82e-05	0.000302	CcSEcCtD
Melatonin—Thrombocytopenia—Capecitabine—breast cancer	2.82e-05	0.000302	CcSEcCtD
Melatonin—Cardiac disorder—Methotrexate—breast cancer	2.8e-05	0.0003	CcSEcCtD
Melatonin—Skin disorder—Capecitabine—breast cancer	2.8e-05	0.000299	CcSEcCtD
Melatonin—Urinary tract disorder—Epirubicin—breast cancer	2.79e-05	0.000298	CcSEcCtD
Melatonin—Haematuria—Doxorubicin—breast cancer	2.78e-05	0.000297	CcSEcCtD
Melatonin—Connective tissue disorder—Epirubicin—breast cancer	2.78e-05	0.000297	CcSEcCtD
Melatonin—Abdominal pain—Paclitaxel—breast cancer	2.77e-05	0.000297	CcSEcCtD
Melatonin—Urethral disorder—Epirubicin—breast cancer	2.77e-05	0.000296	CcSEcCtD
Melatonin—Hepatobiliary disease—Doxorubicin—breast cancer	2.75e-05	0.000295	CcSEcCtD
Melatonin—Angiopathy—Methotrexate—breast cancer	2.74e-05	0.000293	CcSEcCtD
Melatonin—Vomiting—Mitoxantrone—breast cancer	2.74e-05	0.000293	CcSEcCtD
Melatonin—Vomiting—Irinotecan—breast cancer	2.74e-05	0.000293	CcSEcCtD
Melatonin—Immune system disorder—Methotrexate—breast cancer	2.73e-05	0.000292	CcSEcCtD
Melatonin—Dizziness—Fluorouracil—breast cancer	2.73e-05	0.000292	CcSEcCtD
Melatonin—Rash—Mitoxantrone—breast cancer	2.71e-05	0.00029	CcSEcCtD
Melatonin—Rash—Irinotecan—breast cancer	2.71e-05	0.00029	CcSEcCtD
Melatonin—Dermatitis—Mitoxantrone—breast cancer	2.71e-05	0.00029	CcSEcCtD
Melatonin—Dermatitis—Irinotecan—breast cancer	2.71e-05	0.00029	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Docetaxel—breast cancer	2.71e-05	0.00029	CcSEcCtD
Melatonin—Headache—Irinotecan—breast cancer	2.7e-05	0.000288	CcSEcCtD
Melatonin—Headache—Mitoxantrone—breast cancer	2.7e-05	0.000288	CcSEcCtD
Melatonin—Insomnia—Docetaxel—breast cancer	2.69e-05	0.000288	CcSEcCtD
Melatonin—Paraesthesia—Docetaxel—breast cancer	2.67e-05	0.000286	CcSEcCtD
Melatonin—Vomiting—Gemcitabine—breast cancer	2.67e-05	0.000285	CcSEcCtD
Melatonin—Somnolence—Docetaxel—breast cancer	2.64e-05	0.000283	CcSEcCtD
Melatonin—Mental disorder—Methotrexate—breast cancer	2.64e-05	0.000283	CcSEcCtD
Melatonin—Rash—Gemcitabine—breast cancer	2.64e-05	0.000283	CcSEcCtD
Melatonin—Dermatitis—Gemcitabine—breast cancer	2.64e-05	0.000282	CcSEcCtD
Melatonin—Eye disorder—Epirubicin—breast cancer	2.64e-05	0.000282	CcSEcCtD
Melatonin—Malnutrition—Methotrexate—breast cancer	2.63e-05	0.000281	CcSEcCtD
Melatonin—Erythema—Methotrexate—breast cancer	2.63e-05	0.000281	CcSEcCtD
Melatonin—Headache—Gemcitabine—breast cancer	2.63e-05	0.000281	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Capecitabine—breast cancer	2.62e-05	0.000281	CcSEcCtD
Melatonin—Cardiac disorder—Epirubicin—breast cancer	2.62e-05	0.00028	CcSEcCtD
Melatonin—Vomiting—Fluorouracil—breast cancer	2.62e-05	0.00028	CcSEcCtD
Melatonin—Dyspepsia—Docetaxel—breast cancer	2.62e-05	0.00028	CcSEcCtD
Melatonin—Insomnia—Capecitabine—breast cancer	2.61e-05	0.000279	CcSEcCtD
Melatonin—Rash—Fluorouracil—breast cancer	2.6e-05	0.000278	CcSEcCtD
Melatonin—Dermatitis—Fluorouracil—breast cancer	2.6e-05	0.000278	CcSEcCtD
Melatonin—Paraesthesia—Capecitabine—breast cancer	2.59e-05	0.000277	CcSEcCtD
Melatonin—Hypersensitivity—Paclitaxel—breast cancer	2.59e-05	0.000277	CcSEcCtD
Melatonin—Headache—Fluorouracil—breast cancer	2.58e-05	0.000276	CcSEcCtD
Melatonin—Urinary tract disorder—Doxorubicin—breast cancer	2.58e-05	0.000276	CcSEcCtD
Melatonin—Gastrointestinal disorder—Docetaxel—breast cancer	2.57e-05	0.000275	CcSEcCtD
Melatonin—Connective tissue disorder—Doxorubicin—breast cancer	2.57e-05	0.000275	CcSEcCtD
Melatonin—Fatigue—Docetaxel—breast cancer	2.56e-05	0.000274	CcSEcCtD
Melatonin—Angiopathy—Epirubicin—breast cancer	2.56e-05	0.000274	CcSEcCtD
Melatonin—Urethral disorder—Doxorubicin—breast cancer	2.56e-05	0.000274	CcSEcCtD
Melatonin—Nausea—Irinotecan—breast cancer	2.56e-05	0.000273	CcSEcCtD
Melatonin—Nausea—Mitoxantrone—breast cancer	2.56e-05	0.000273	CcSEcCtD
Melatonin—Immune system disorder—Epirubicin—breast cancer	2.55e-05	0.000273	CcSEcCtD
Melatonin—Pain—Docetaxel—breast cancer	2.54e-05	0.000272	CcSEcCtD
Melatonin—Back pain—Methotrexate—breast cancer	2.54e-05	0.000272	CcSEcCtD
Melatonin—Dyspepsia—Capecitabine—breast cancer	2.54e-05	0.000271	CcSEcCtD
Melatonin—Asthenia—Paclitaxel—breast cancer	2.52e-05	0.000269	CcSEcCtD
Melatonin—Nausea—Gemcitabine—breast cancer	2.49e-05	0.000266	CcSEcCtD
Melatonin—Gastrointestinal disorder—Capecitabine—breast cancer	2.49e-05	0.000266	CcSEcCtD
Melatonin—Fatigue—Capecitabine—breast cancer	2.48e-05	0.000266	CcSEcCtD
Melatonin—Pruritus—Paclitaxel—breast cancer	2.48e-05	0.000266	CcSEcCtD
Melatonin—Vision blurred—Methotrexate—breast cancer	2.48e-05	0.000265	CcSEcCtD
Melatonin—Mental disorder—Epirubicin—breast cancer	2.47e-05	0.000265	CcSEcCtD
Melatonin—Pain—Capecitabine—breast cancer	2.46e-05	0.000263	CcSEcCtD
Melatonin—Erythema—Epirubicin—breast cancer	2.46e-05	0.000263	CcSEcCtD
Melatonin—Malnutrition—Epirubicin—breast cancer	2.46e-05	0.000263	CcSEcCtD
Melatonin—Nausea—Fluorouracil—breast cancer	2.45e-05	0.000262	CcSEcCtD
Melatonin—Eye disorder—Doxorubicin—breast cancer	2.44e-05	0.000261	CcSEcCtD
Melatonin—Gastrointestinal pain—Docetaxel—breast cancer	2.43e-05	0.00026	CcSEcCtD
Melatonin—Cardiac disorder—Doxorubicin—breast cancer	2.43e-05	0.000259	CcSEcCtD
Melatonin—Flatulence—Epirubicin—breast cancer	2.42e-05	0.000259	CcSEcCtD
Melatonin—Tension—Epirubicin—breast cancer	2.41e-05	0.000258	CcSEcCtD
Melatonin—Nervousness—Epirubicin—breast cancer	2.39e-05	0.000255	CcSEcCtD
Melatonin—Back pain—Epirubicin—breast cancer	2.38e-05	0.000254	CcSEcCtD
Melatonin—Angiopathy—Doxorubicin—breast cancer	2.37e-05	0.000254	CcSEcCtD
Melatonin—Muscle spasms—Epirubicin—breast cancer	2.36e-05	0.000253	CcSEcCtD
Melatonin—Immune system disorder—Doxorubicin—breast cancer	2.36e-05	0.000253	CcSEcCtD
Melatonin—Vertigo—Methotrexate—breast cancer	2.36e-05	0.000253	CcSEcCtD
Melatonin—Gastrointestinal pain—Capecitabine—breast cancer	2.36e-05	0.000252	CcSEcCtD
Melatonin—Abdominal pain—Docetaxel—breast cancer	2.35e-05	0.000252	CcSEcCtD
Melatonin—Leukopenia—Methotrexate—breast cancer	2.35e-05	0.000252	CcSEcCtD
Melatonin—Dizziness—Paclitaxel—breast cancer	2.32e-05	0.000248	CcSEcCtD
Melatonin—Vision blurred—Epirubicin—breast cancer	2.32e-05	0.000248	CcSEcCtD
Melatonin—Mental disorder—Doxorubicin—breast cancer	2.29e-05	0.000245	CcSEcCtD
Melatonin—Abdominal pain—Capecitabine—breast cancer	2.28e-05	0.000244	CcSEcCtD
Melatonin—Erythema—Doxorubicin—breast cancer	2.27e-05	0.000243	CcSEcCtD
Melatonin—Malnutrition—Doxorubicin—breast cancer	2.27e-05	0.000243	CcSEcCtD
Melatonin—Agitation—Epirubicin—breast cancer	2.26e-05	0.000242	CcSEcCtD
Melatonin—Flatulence—Doxorubicin—breast cancer	2.24e-05	0.00024	CcSEcCtD
Melatonin—Chest pain—Methotrexate—breast cancer	2.24e-05	0.000239	CcSEcCtD
Melatonin—Arthralgia—Methotrexate—breast cancer	2.24e-05	0.000239	CcSEcCtD
Melatonin—Tension—Doxorubicin—breast cancer	2.23e-05	0.000239	CcSEcCtD
Melatonin—Vomiting—Paclitaxel—breast cancer	2.23e-05	0.000239	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	2.22e-05	0.000238	CcSEcCtD
Melatonin—Rash—Paclitaxel—breast cancer	2.21e-05	0.000237	CcSEcCtD
Melatonin—Dermatitis—Paclitaxel—breast cancer	2.21e-05	0.000237	CcSEcCtD
Melatonin—Nervousness—Doxorubicin—breast cancer	2.21e-05	0.000236	CcSEcCtD
Melatonin—Vertigo—Epirubicin—breast cancer	2.21e-05	0.000236	CcSEcCtD
Melatonin—Syncope—Epirubicin—breast cancer	2.2e-05	0.000236	CcSEcCtD
Melatonin—Leukopenia—Epirubicin—breast cancer	2.2e-05	0.000235	CcSEcCtD
Melatonin—Back pain—Doxorubicin—breast cancer	2.2e-05	0.000235	CcSEcCtD
Melatonin—Headache—Paclitaxel—breast cancer	2.2e-05	0.000235	CcSEcCtD
Melatonin—Hypersensitivity—Docetaxel—breast cancer	2.19e-05	0.000234	CcSEcCtD
Melatonin—Muscle spasms—Doxorubicin—breast cancer	2.19e-05	0.000234	CcSEcCtD
Melatonin—Palpitations—Epirubicin—breast cancer	2.17e-05	0.000232	CcSEcCtD
Melatonin—Loss of consciousness—Epirubicin—breast cancer	2.16e-05	0.000231	CcSEcCtD
Melatonin—Vision blurred—Doxorubicin—breast cancer	2.14e-05	0.000229	CcSEcCtD
Melatonin—Asthenia—Docetaxel—breast cancer	2.13e-05	0.000228	CcSEcCtD
Melatonin—Infection—Methotrexate—breast cancer	2.13e-05	0.000228	CcSEcCtD
Melatonin—Hypertension—Epirubicin—breast cancer	2.12e-05	0.000227	CcSEcCtD
Melatonin—Hypersensitivity—Capecitabine—breast cancer	2.12e-05	0.000227	CcSEcCtD
Melatonin—Pruritus—Docetaxel—breast cancer	2.1e-05	0.000225	CcSEcCtD
Melatonin—Nervous system disorder—Methotrexate—breast cancer	2.1e-05	0.000225	CcSEcCtD
Melatonin—Thrombocytopenia—Methotrexate—breast cancer	2.1e-05	0.000225	CcSEcCtD
Melatonin—Chest pain—Epirubicin—breast cancer	2.09e-05	0.000224	CcSEcCtD
Melatonin—Arthralgia—Epirubicin—breast cancer	2.09e-05	0.000224	CcSEcCtD
Melatonin—Agitation—Doxorubicin—breast cancer	2.09e-05	0.000224	CcSEcCtD
Melatonin—Anxiety—Epirubicin—breast cancer	2.09e-05	0.000223	CcSEcCtD
Melatonin—Nausea—Paclitaxel—breast cancer	2.08e-05	0.000223	CcSEcCtD
Melatonin—Skin disorder—Methotrexate—breast cancer	2.08e-05	0.000223	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.08e-05	0.000222	CcSEcCtD
Melatonin—Asthenia—Capecitabine—breast cancer	2.07e-05	0.000221	CcSEcCtD
Melatonin—Dry mouth—Epirubicin—breast cancer	2.05e-05	0.000219	CcSEcCtD
Melatonin—Vertigo—Doxorubicin—breast cancer	2.04e-05	0.000219	CcSEcCtD
Melatonin—Syncope—Doxorubicin—breast cancer	2.04e-05	0.000218	CcSEcCtD
Melatonin—Pruritus—Capecitabine—breast cancer	2.04e-05	0.000218	CcSEcCtD
Melatonin—Leukopenia—Doxorubicin—breast cancer	2.04e-05	0.000218	CcSEcCtD
Melatonin—Palpitations—Doxorubicin—breast cancer	2.01e-05	0.000215	CcSEcCtD
Melatonin—Loss of consciousness—Doxorubicin—breast cancer	2e-05	0.000214	CcSEcCtD
Melatonin—Infection—Epirubicin—breast cancer	1.99e-05	0.000213	CcSEcCtD
Melatonin—Shock—Epirubicin—breast cancer	1.97e-05	0.000211	CcSEcCtD
Melatonin—Nervous system disorder—Epirubicin—breast cancer	1.97e-05	0.000211	CcSEcCtD
Melatonin—Dizziness—Docetaxel—breast cancer	1.97e-05	0.00021	CcSEcCtD
Melatonin—Thrombocytopenia—Epirubicin—breast cancer	1.96e-05	0.00021	CcSEcCtD
Melatonin—Hypertension—Doxorubicin—breast cancer	1.96e-05	0.00021	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Methotrexate—breast cancer	1.95e-05	0.000209	CcSEcCtD
Melatonin—Skin disorder—Epirubicin—breast cancer	1.95e-05	0.000208	CcSEcCtD
Melatonin—Insomnia—Methotrexate—breast cancer	1.94e-05	0.000207	CcSEcCtD
Melatonin—Chest pain—Doxorubicin—breast cancer	1.94e-05	0.000207	CcSEcCtD
Melatonin—Arthralgia—Doxorubicin—breast cancer	1.94e-05	0.000207	CcSEcCtD
Melatonin—Anxiety—Doxorubicin—breast cancer	1.93e-05	0.000206	CcSEcCtD
Melatonin—Paraesthesia—Methotrexate—breast cancer	1.93e-05	0.000206	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	1.92e-05	0.000206	CcSEcCtD
Melatonin—Somnolence—Methotrexate—breast cancer	1.91e-05	0.000204	CcSEcCtD
Melatonin—Dizziness—Capecitabine—breast cancer	1.9e-05	0.000204	CcSEcCtD
Melatonin—Dry mouth—Doxorubicin—breast cancer	1.89e-05	0.000203	CcSEcCtD
Melatonin—Vomiting—Docetaxel—breast cancer	1.89e-05	0.000202	CcSEcCtD
Melatonin—Dyspepsia—Methotrexate—breast cancer	1.89e-05	0.000202	CcSEcCtD
Melatonin—Rash—Docetaxel—breast cancer	1.88e-05	0.000201	CcSEcCtD
Melatonin—Dermatitis—Docetaxel—breast cancer	1.87e-05	0.0002	CcSEcCtD
Melatonin—Headache—Docetaxel—breast cancer	1.86e-05	0.000199	CcSEcCtD
Melatonin—Gastrointestinal disorder—Methotrexate—breast cancer	1.85e-05	0.000198	CcSEcCtD
Melatonin—Fatigue—Methotrexate—breast cancer	1.85e-05	0.000198	CcSEcCtD
Melatonin—Infection—Doxorubicin—breast cancer	1.84e-05	0.000197	CcSEcCtD
Melatonin—Pain—Methotrexate—breast cancer	1.83e-05	0.000196	CcSEcCtD
Melatonin—Vomiting—Capecitabine—breast cancer	1.83e-05	0.000196	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Epirubicin—breast cancer	1.83e-05	0.000196	CcSEcCtD
Melatonin—Shock—Doxorubicin—breast cancer	1.83e-05	0.000195	CcSEcCtD
Melatonin—Nervous system disorder—Doxorubicin—breast cancer	1.82e-05	0.000195	CcSEcCtD
Melatonin—Thrombocytopenia—Doxorubicin—breast cancer	1.82e-05	0.000194	CcSEcCtD
Melatonin—Rash—Capecitabine—breast cancer	1.82e-05	0.000194	CcSEcCtD
Melatonin—Insomnia—Epirubicin—breast cancer	1.81e-05	0.000194	CcSEcCtD
Melatonin—Dermatitis—Capecitabine—breast cancer	1.81e-05	0.000194	CcSEcCtD
Melatonin—Headache—Capecitabine—breast cancer	1.8e-05	0.000193	CcSEcCtD
Melatonin—Skin disorder—Doxorubicin—breast cancer	1.8e-05	0.000193	CcSEcCtD
Melatonin—Paraesthesia—Epirubicin—breast cancer	1.8e-05	0.000193	CcSEcCtD
Melatonin—Somnolence—Epirubicin—breast cancer	1.78e-05	0.000191	CcSEcCtD
Melatonin—Nausea—Docetaxel—breast cancer	1.77e-05	0.000189	CcSEcCtD
Melatonin—Dyspepsia—Epirubicin—breast cancer	1.77e-05	0.000189	CcSEcCtD
Melatonin—Gastrointestinal pain—Methotrexate—breast cancer	1.75e-05	0.000188	CcSEcCtD
Melatonin—Gastrointestinal disorder—Epirubicin—breast cancer	1.73e-05	0.000185	CcSEcCtD
Melatonin—Fatigue—Epirubicin—breast cancer	1.73e-05	0.000185	CcSEcCtD
Melatonin—Pain—Epirubicin—breast cancer	1.72e-05	0.000184	CcSEcCtD
Melatonin—Nausea—Capecitabine—breast cancer	1.71e-05	0.000183	CcSEcCtD
Melatonin—Abdominal pain—Methotrexate—breast cancer	1.7e-05	0.000181	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.69e-05	0.000181	CcSEcCtD
Melatonin—Insomnia—Doxorubicin—breast cancer	1.68e-05	0.00018	CcSEcCtD
Melatonin—Paraesthesia—Doxorubicin—breast cancer	1.67e-05	0.000178	CcSEcCtD
Melatonin—Somnolence—Doxorubicin—breast cancer	1.65e-05	0.000177	CcSEcCtD
Melatonin—Gastrointestinal pain—Epirubicin—breast cancer	1.64e-05	0.000176	CcSEcCtD
Melatonin—Dyspepsia—Doxorubicin—breast cancer	1.63e-05	0.000175	CcSEcCtD
Melatonin—Gastrointestinal disorder—Doxorubicin—breast cancer	1.6e-05	0.000171	CcSEcCtD
Melatonin—Fatigue—Doxorubicin—breast cancer	1.6e-05	0.000171	CcSEcCtD
Melatonin—Pain—Doxorubicin—breast cancer	1.59e-05	0.00017	CcSEcCtD
Melatonin—Abdominal pain—Epirubicin—breast cancer	1.59e-05	0.00017	CcSEcCtD
Melatonin—Hypersensitivity—Methotrexate—breast cancer	1.58e-05	0.000169	CcSEcCtD
Melatonin—Asthenia—Methotrexate—breast cancer	1.54e-05	0.000165	CcSEcCtD
Melatonin—Gastrointestinal pain—Doxorubicin—breast cancer	1.52e-05	0.000162	CcSEcCtD
Melatonin—Pruritus—Methotrexate—breast cancer	1.52e-05	0.000162	CcSEcCtD
Melatonin—Hypersensitivity—Epirubicin—breast cancer	1.48e-05	0.000158	CcSEcCtD
Melatonin—Abdominal pain—Doxorubicin—breast cancer	1.47e-05	0.000157	CcSEcCtD
Melatonin—Asthenia—Epirubicin—breast cancer	1.44e-05	0.000154	CcSEcCtD
Melatonin—Pruritus—Epirubicin—breast cancer	1.42e-05	0.000152	CcSEcCtD
Melatonin—Dizziness—Methotrexate—breast cancer	1.42e-05	0.000152	CcSEcCtD
Melatonin—Hypersensitivity—Doxorubicin—breast cancer	1.37e-05	0.000146	CcSEcCtD
Melatonin—Vomiting—Methotrexate—breast cancer	1.36e-05	0.000146	CcSEcCtD
Melatonin—Rash—Methotrexate—breast cancer	1.35e-05	0.000145	CcSEcCtD
Melatonin—Dermatitis—Methotrexate—breast cancer	1.35e-05	0.000144	CcSEcCtD
Melatonin—Headache—Methotrexate—breast cancer	1.34e-05	0.000144	CcSEcCtD
Melatonin—Asthenia—Doxorubicin—breast cancer	1.33e-05	0.000143	CcSEcCtD
Melatonin—Dizziness—Epirubicin—breast cancer	1.33e-05	0.000142	CcSEcCtD
Melatonin—Pruritus—Doxorubicin—breast cancer	1.31e-05	0.000141	CcSEcCtD
Melatonin—Vomiting—Epirubicin—breast cancer	1.28e-05	0.000136	CcSEcCtD
Melatonin—Nausea—Methotrexate—breast cancer	1.27e-05	0.000136	CcSEcCtD
Melatonin—Rash—Epirubicin—breast cancer	1.27e-05	0.000135	CcSEcCtD
Melatonin—Dermatitis—Epirubicin—breast cancer	1.26e-05	0.000135	CcSEcCtD
Melatonin—Headache—Epirubicin—breast cancer	1.26e-05	0.000134	CcSEcCtD
Melatonin—Dizziness—Doxorubicin—breast cancer	1.23e-05	0.000131	CcSEcCtD
Melatonin—Nausea—Epirubicin—breast cancer	1.19e-05	0.000128	CcSEcCtD
Melatonin—Vomiting—Doxorubicin—breast cancer	1.18e-05	0.000126	CcSEcCtD
Melatonin—Rash—Doxorubicin—breast cancer	1.17e-05	0.000125	CcSEcCtD
Melatonin—Dermatitis—Doxorubicin—breast cancer	1.17e-05	0.000125	CcSEcCtD
Melatonin—Headache—Doxorubicin—breast cancer	1.16e-05	0.000124	CcSEcCtD
Melatonin—Nausea—Doxorubicin—breast cancer	1.1e-05	0.000118	CcSEcCtD
Melatonin—CALM3—Signaling Pathways—IGF1—breast cancer	5.48e-07	5.74e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—AKT2—breast cancer	5.47e-07	5.74e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—PTEN—breast cancer	5.47e-07	5.73e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—PTEN—breast cancer	5.47e-07	5.73e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—EGFR—breast cancer	5.45e-07	5.71e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—BRAF—breast cancer	5.44e-07	5.7e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—BRAF—breast cancer	5.44e-07	5.7e-06	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PTGS2—breast cancer	5.43e-07	5.69e-06	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—PIK3CA—breast cancer	5.35e-07	5.6e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	5.31e-07	5.57e-06	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PIK3CB—breast cancer	5.3e-07	5.56e-06	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PIK3CB—breast cancer	5.3e-07	5.56e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—STAT3—breast cancer	5.3e-07	5.55e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—STAT3—breast cancer	5.3e-07	5.55e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IGF1—breast cancer	5.3e-07	5.55e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IGF1—breast cancer	5.3e-07	5.55e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—AKT2—breast cancer	5.3e-07	5.55e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—AKT2—breast cancer	5.3e-07	5.55e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—EGFR—breast cancer	5.27e-07	5.52e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—EGFR—breast cancer	5.27e-07	5.52e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—SRC—breast cancer	5.26e-07	5.51e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PIK3CD—breast cancer	5.26e-07	5.51e-06	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PTGS2—breast cancer	5.26e-07	5.51e-06	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PTGS2—breast cancer	5.26e-07	5.51e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—SRC—breast cancer	5.25e-07	5.5e-06	CbGpPWpGaD
Melatonin—CALM3—Immune System—MAPK3—breast cancer	5.24e-07	5.48e-06	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PIK3CB—breast cancer	5.2e-07	5.45e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—SERPINE1—breast cancer	5.2e-07	5.45e-06	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PTGS2—breast cancer	5.15e-07	5.4e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—MTHFR—breast cancer	5.15e-07	5.4e-06	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—PIK3CA—breast cancer	5.15e-07	5.4e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—KRAS—breast cancer	5.15e-07	5.39e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—VEGFA—breast cancer	5.13e-07	5.37e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PIK3CD—breast cancer	5.09e-07	5.33e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PIK3CD—breast cancer	5.09e-07	5.33e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—SRC—breast cancer	5.07e-07	5.32e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—SRC—breast cancer	5.07e-07	5.32e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—STAT3—breast cancer	5.07e-07	5.32e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PIK3CG—breast cancer	5.07e-07	5.31e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—MAPK3—breast cancer	5.06e-07	5.31e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—MAPK3—breast cancer	5.06e-07	5.31e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—STAT3—breast cancer	5.06e-07	5.3e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—SERPINE1—breast cancer	5.03e-07	5.27e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—SERPINE1—breast cancer	5.03e-07	5.27e-06	CbGpPWpGaD
Melatonin—ESR1—Gene Expression—AKT1—breast cancer	5.03e-07	5.27e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—KRAS—breast cancer	4.98e-07	5.22e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—KRAS—breast cancer	4.98e-07	5.22e-06	CbGpPWpGaD
Melatonin—CALM3—Immune System—EGFR—breast cancer	4.98e-07	5.22e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—NOS3—breast cancer	4.97e-07	5.2e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—STAT3—breast cancer	4.89e-07	5.13e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—STAT3—breast cancer	4.89e-07	5.13e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PIK3CD—breast cancer	4.88e-07	5.12e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—MAPK3—breast cancer	4.85e-07	5.08e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—MAPK3—breast cancer	4.83e-07	5.06e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—ALB—breast cancer	4.82e-07	5.05e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—EGFR—breast cancer	4.82e-07	5.05e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—EGFR—breast cancer	4.82e-07	5.05e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—NOS3—breast cancer	4.8e-07	5.03e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—NOS3—breast cancer	4.8e-07	5.03e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—CAV1—breast cancer	4.75e-07	4.98e-06	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PTEN—breast cancer	4.74e-07	4.96e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—PIK3CA—breast cancer	4.73e-07	4.96e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—MYC—breast cancer	4.72e-07	4.94e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MDM2—breast cancer	4.71e-07	4.94e-06	CbGpPWpGaD
Melatonin—CALM3—Immune System—KRAS—breast cancer	4.7e-07	4.93e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—TGFB1—breast cancer	4.7e-07	4.93e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—MYC—breast cancer	4.7e-07	4.93e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—RAF1—breast cancer	4.7e-07	4.92e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—TGFB1—breast cancer	4.69e-07	4.91e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—MAPK3—breast cancer	4.68e-07	4.9e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—MAPK3—breast cancer	4.68e-07	4.9e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—RELA—breast cancer	4.67e-07	4.9e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—ERBB2—breast cancer	4.65e-07	4.87e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—EGFR—breast cancer	4.61e-07	4.83e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—NOS3—breast cancer	4.61e-07	4.83e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—EGFR—breast cancer	4.6e-07	4.82e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MTOR—breast cancer	4.58e-07	4.8e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PIK3CB—breast cancer	4.58e-07	4.8e-06	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PTEN—breast cancer	4.58e-07	4.8e-06	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PTEN—breast cancer	4.58e-07	4.8e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—PIK3CA—breast cancer	4.58e-07	4.79e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—PIK3CA—breast cancer	4.58e-07	4.79e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MDM2—breast cancer	4.56e-07	4.78e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MDM2—breast cancer	4.56e-07	4.78e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—KRAS—breast cancer	4.55e-07	4.77e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—KRAS—breast cancer	4.55e-07	4.77e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—MYC—breast cancer	4.55e-07	4.76e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—MYC—breast cancer	4.55e-07	4.76e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—RAF1—breast cancer	4.54e-07	4.76e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—RAF1—breast cancer	4.54e-07	4.76e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.54e-07	4.76e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—TGFB1—breast cancer	4.54e-07	4.75e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—TGFB1—breast cancer	4.54e-07	4.75e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—RELA—breast cancer	4.52e-07	4.74e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—RELA—breast cancer	4.52e-07	4.74e-06	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PTEN—breast cancer	4.5e-07	4.71e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—ERBB2—breast cancer	4.49e-07	4.71e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—ERBB2—breast cancer	4.49e-07	4.71e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PIK3CD—breast cancer	4.45e-07	4.67e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—EGFR—breast cancer	4.45e-07	4.66e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—EGFR—breast cancer	4.45e-07	4.66e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PIK3CB—breast cancer	4.43e-07	4.65e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MTOR—breast cancer	4.43e-07	4.65e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MTOR—breast cancer	4.43e-07	4.65e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PIK3CB—breast cancer	4.43e-07	4.65e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CXCL8—breast cancer	4.41e-07	4.62e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—ALB—breast cancer	4.4e-07	4.61e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—HRAS—breast cancer	4.38e-07	4.59e-06	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—AKT1—breast cancer	4.37e-07	4.58e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—KRAS—breast cancer	4.36e-07	4.56e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—KRAS—breast cancer	4.34e-07	4.55e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PIK3CG—breast cancer	4.33e-07	4.54e-06	CbGpPWpGaD
Melatonin—CALM3—Immune System—PIK3CA—breast cancer	4.32e-07	4.53e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CDKN1B—breast cancer	4.3e-07	4.51e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CXCL8—breast cancer	4.26e-07	4.46e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CXCL8—breast cancer	4.26e-07	4.46e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PIK3CB—breast cancer	4.26e-07	4.46e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—HRAS—breast cancer	4.23e-07	4.44e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—HRAS—breast cancer	4.23e-07	4.44e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PTGS2—breast cancer	4.22e-07	4.42e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CASP3—breast cancer	4.22e-07	4.42e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IL2—breast cancer	4.21e-07	4.41e-06	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—AKT1—breast cancer	4.21e-07	4.41e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—NOS3—breast cancer	4.21e-07	4.41e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—KRAS—breast cancer	4.2e-07	4.4e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—KRAS—breast cancer	4.2e-07	4.4e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—IL6—breast cancer	4.19e-07	4.39e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—PIK3CA—breast cancer	4.18e-07	4.38e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—PIK3CA—breast cancer	4.18e-07	4.38e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CDKN1B—breast cancer	4.16e-07	4.36e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CDKN1B—breast cancer	4.16e-07	4.36e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CCND1—breast cancer	4.1e-07	4.3e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—JUN—breast cancer	4.1e-07	4.29e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CASP3—breast cancer	4.08e-07	4.27e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CASP3—breast cancer	4.08e-07	4.27e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IL2—breast cancer	4.07e-07	4.27e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IL2—breast cancer	4.07e-07	4.27e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CTNNB1—breast cancer	4.06e-07	4.26e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—IL6—breast cancer	4.05e-07	4.25e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—IL6—breast cancer	4.05e-07	4.25e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—PIK3CA—breast cancer	4e-07	4.19e-06	CbGpPWpGaD
Melatonin—CALM3—Immune System—HRAS—breast cancer	4e-07	4.19e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—PIK3CA—breast cancer	3.99e-07	4.18e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MMP9—breast cancer	3.98e-07	4.17e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CDKN1A—breast cancer	3.97e-07	4.16e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CCND1—breast cancer	3.97e-07	4.16e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CCND1—breast cancer	3.97e-07	4.16e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—JUN—breast cancer	3.96e-07	4.15e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—JUN—breast cancer	3.96e-07	4.15e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PTEN—breast cancer	3.96e-07	4.15e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CTNNB1—breast cancer	3.93e-07	4.12e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CTNNB1—breast cancer	3.93e-07	4.12e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PIK3CB—breast cancer	3.88e-07	4.07e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MAPK8—breast cancer	3.88e-07	4.06e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—TP53—breast cancer	3.87e-07	4.06e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—HRAS—breast cancer	3.87e-07	4.05e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—HRAS—breast cancer	3.87e-07	4.05e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—AKT1—breast cancer	3.86e-07	4.05e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—PIK3CA—breast cancer	3.86e-07	4.04e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—PIK3CA—breast cancer	3.86e-07	4.04e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MMP9—breast cancer	3.85e-07	4.04e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MMP9—breast cancer	3.85e-07	4.04e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PTGS2—breast cancer	3.85e-07	4.03e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CDKN1A—breast cancer	3.84e-07	4.02e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CDKN1A—breast cancer	3.84e-07	4.02e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PTEN—breast cancer	3.83e-07	4.01e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PTEN—breast cancer	3.83e-07	4.01e-06	CbGpPWpGaD
Melatonin—CALM3—Immune System—IL6—breast cancer	3.83e-07	4.01e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PIK3CD—breast cancer	3.81e-07	3.99e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—ALB—breast cancer	3.76e-07	3.94e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MAPK8—breast cancer	3.75e-07	3.93e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MAPK8—breast cancer	3.75e-07	3.93e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—AKT1—breast cancer	3.74e-07	3.92e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—AKT1—breast cancer	3.74e-07	3.92e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—HRAS—breast cancer	3.7e-07	3.88e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—IL6—breast cancer	3.7e-07	3.88e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—IL6—breast cancer	3.7e-07	3.88e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—HRAS—breast cancer	3.69e-07	3.87e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PTEN—breast cancer	3.68e-07	3.85e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—SRC—breast cancer	3.67e-07	3.85e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—NOS3—breast cancer	3.59e-07	3.76e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—VEGFA—breast cancer	3.58e-07	3.75e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—HRAS—breast cancer	3.57e-07	3.74e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—HRAS—breast cancer	3.57e-07	3.74e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—SRC—breast cancer	3.55e-07	3.72e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—SRC—breast cancer	3.55e-07	3.72e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—IL6—breast cancer	3.54e-07	3.71e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—STAT3—breast cancer	3.54e-07	3.71e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—IL6—breast cancer	3.53e-07	3.7e-06	CbGpPWpGaD
Melatonin—CALM3—Immune System—AKT1—breast cancer	3.53e-07	3.7e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—VEGFA—breast cancer	3.46e-07	3.63e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—VEGFA—breast cancer	3.46e-07	3.63e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—STAT3—breast cancer	3.43e-07	3.59e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—STAT3—breast cancer	3.43e-07	3.59e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—IL6—breast cancer	3.42e-07	3.58e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—IL6—breast cancer	3.42e-07	3.58e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—AKT1—breast cancer	3.42e-07	3.58e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—AKT1—breast cancer	3.42e-07	3.58e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MAPK3—breast cancer	3.38e-07	3.55e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PTEN—breast cancer	3.35e-07	3.51e-06	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PIK3CA—breast cancer	3.34e-07	3.5e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PIK3CB—breast cancer	3.32e-07	3.48e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MYC—breast cancer	3.29e-07	3.45e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PTGS2—breast cancer	3.29e-07	3.44e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—TGFB1—breast cancer	3.28e-07	3.44e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MAPK3—breast cancer	3.27e-07	3.43e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MAPK3—breast cancer	3.27e-07	3.43e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—AKT1—breast cancer	3.27e-07	3.43e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—AKT1—breast cancer	3.26e-07	3.42e-06	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PIK3CA—breast cancer	3.23e-07	3.39e-06	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PIK3CA—breast cancer	3.23e-07	3.39e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—EGFR—breast cancer	3.22e-07	3.37e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MYC—breast cancer	3.18e-07	3.34e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MYC—breast cancer	3.18e-07	3.34e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—TGFB1—breast cancer	3.18e-07	3.33e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—TGFB1—breast cancer	3.18e-07	3.33e-06	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PIK3CA—breast cancer	3.17e-07	3.32e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—AKT1—breast cancer	3.15e-07	3.3e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—AKT1—breast cancer	3.15e-07	3.3e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—EGFR—breast cancer	3.11e-07	3.26e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—EGFR—breast cancer	3.11e-07	3.26e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—KRAS—breast cancer	3.04e-07	3.19e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—KRAS—breast cancer	2.94e-07	3.08e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—KRAS—breast cancer	2.94e-07	3.08e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PTEN—breast cancer	2.87e-07	3e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PIK3CA—breast cancer	2.79e-07	2.93e-06	CbGpPWpGaD
Melatonin—CALM3—Metabolism—AKT1—breast cancer	2.73e-07	2.86e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—TP53—breast cancer	2.7e-07	2.83e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PIK3CA—breast cancer	2.7e-07	2.83e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PIK3CA—breast cancer	2.7e-07	2.83e-06	CbGpPWpGaD
Melatonin—CALM2—Metabolism—AKT1—breast cancer	2.64e-07	2.77e-06	CbGpPWpGaD
Melatonin—CALM1—Metabolism—AKT1—breast cancer	2.64e-07	2.77e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—TP53—breast cancer	2.62e-07	2.74e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—TP53—breast cancer	2.62e-07	2.74e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PIK3CA—breast cancer	2.6e-07	2.72e-06	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—AKT1—breast cancer	2.59e-07	2.71e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—HRAS—breast cancer	2.59e-07	2.71e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—HRAS—breast cancer	2.5e-07	2.62e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—HRAS—breast cancer	2.5e-07	2.62e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IL6—breast cancer	2.47e-07	2.59e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IL6—breast cancer	2.39e-07	2.51e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IL6—breast cancer	2.39e-07	2.51e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PIK3CA—breast cancer	2.37e-07	2.48e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—AKT1—breast cancer	2.28e-07	2.39e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—AKT1—breast cancer	2.21e-07	2.31e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—AKT1—breast cancer	2.21e-07	2.31e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—AKT1—breast cancer	2.12e-07	2.22e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PIK3CA—breast cancer	2.02e-07	2.12e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—AKT1—breast cancer	1.93e-07	2.03e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—AKT1—breast cancer	1.65e-07	1.73e-06	CbGpPWpGaD
